| Application no. and date | 17728614.3 (espacenet) (Federated) (European Patent Register), 20170601 | | Patent/reg. no. and date | DK/EP 3464265, 20220713 | | Publication date | 20190410 | | Priority no. and date | US 201662344059 P, 20160601, GB 201609607, 20160601 | | EP pub. no. and date |
EP 3464265 20190410 | | Effective date | | | Applicant/owner | Kalvista Pharmaceuticals Limited, Porton Science Park
Bybrook Road
Porton Down
Wiltshire SP4 0BF, GB | | Applicant ref. no. | P80267DK01 | | Inventor | EDWARDS, Hannah Joy, c/o KALVISTA PHARMACEUTICALS LIMITED
Building 227
Tetricus Science Park
Porton Down
Salisbury SP4 0JQ, GB,
CROWE, David Malcolm, 5 Boulton Road
Reading RG2 0NH, GB,
BEATON, Haydn, 1 Bayliss Close
Quorn
Loughborough LE12 8PF, GB,
GRIFFITHS-HAYNES, Nicholas James, 24 Brookside Avenue
Pailton
Warwickshire CV23 0QG, GB | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/4439 (2006.01) , A61P 29/00 (2006.01) , C07D 401/10 (2006.01) | | Title | POLYMORPHER AF N-[(3-FLUOR-4-METHOXYPYRIDIN-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({4-[2-OXOPYRIDIN-1-YL)METHYL]PHENYL}METHYL)PYRAZOL-4-CARBOXAMID SOM KALLIKREIN-INHIBITORER | | Int. application no. | GB2017051579 | | Int. publication no. | WO2017208005 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
